Results 301 to 310 of about 17,208,238 (361)

Ligand binding at the protein–lipid interface: strategic considerations for drug design

Nature reviews. Drug discovery, 2021
J. Payandeh, M. Volgraf
semanticscholar   +1 more source

Graph neural networks for automated de novo drug design.

Drug Discovery Today, 2021
Jiacheng Xiong, Zhaoping Xiong, Kaixian Chen, Hualiang Jiang, M. Zheng   +4 more
semanticscholar   +1 more source

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Drug Design: Designer Drugs

2010
Gerd Folkers, Elvan Kut, Martin Boyer
openaire   +1 more source

Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design.

Journal of Medicinal Chemistry, 2018
N. Meanwell
semanticscholar   +1 more source

Rational drug design

Transplant Immunology, 2002
openaire   +2 more sources

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Designer Drugs

2022
Neelambika Revadigar, Ching Tary Yu, Isabelle Silverstone-Simard   +2 more
openaire   +1 more source

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle, Taofeek Kunle Owonikoko, Nabil F Saba   +2 more
exaly